Numab Therapeutics AG’s Post

With the Biopharma industry starting to build a stronger understanding around the needs and assessments of their mRNA therapeutics, one of the biggest impacts that have been uncovered is the importance of Poly(A) tail length determination and how it effects efficiency and stability of your final product. In the technote below, the SCIEX tech team has developed a simplified workflow for Poly(A) tail analysis to achieve single base resolution for accurate sizing determination on our PA800 plus system. Take a look at this outstanding workflow for a valuable CQA in mRNA assessment! #SCIEX #CE #biopharma #pharma #biotechnology #mRNA #RNA

At Genotipia's Third Spanish Meeting on Oligonucleotide Therapeutics, Judy will present "#CMC Strategies to Assure #Quality While Accelerating Development of #Oligonucleotides." She will speak tomorrow at 9:30 am ET during Section IV: Session Preclinical Tools and Development. Her presentation will discuss the necessary steps to execute to assure quality of your oligonucleotide APIs and DPs, and compliance with agency expectations, throughout development. Details here >> https://lnkd.in/dF_7i8Gj   #biotech #quality #pharma #API

It's been approximately five years since the first PROTAC degraders (vepdegestrant and bavdegalutamide) entered clinical trials. Since this milestone, Targeted Protein Degradation and its therapeutic applications have continued to advance rapidly – and this trend shows no sign of slowing down anytime soon!      If you want to catch up on the state of the TPD world, check out our most recent blog post: https://lnkd.in/dwB7u_Jj     Inside, you'll find all the information you need to…  💡...understand the unique advantages of TPD-based strategies.   💡…evaluate the clinical successes of existing PROTAC drugs.   💡… forecast the promising future of TPD therapeutics based on an extensive body of exciting pre-clinical research.      And if you're ready to take advantage of the power of TPD to accelerate your drug discovery project, contact us at momentum.bio/contact    #TPD #PROTAC #DrugDiscovery #Biotech 

Are you curious about how nuclear medicine can contribute to the advancement of immunotherapy in oncology? This article elaborates on how CD8 ImmunoPET is a potential game-changer within immuno-oncology research, providing unique insights into the mechanism of action of drug candidates in clinical trials. #precisionmedicine #immunooncology #ASCO

"To select the best lead antibody for clinical use, it’s crucial to have a diverse panel of lead candidates." Join Andra Li, Ph.D. for her presentation at our Antibody Therapeutics Roundtable Xchange happening in #SanDiego, February 26th. To secure your spot, view full agendas and more, please visit https://lnkd.in/ew2y26Yv Please note: Registration is only open to Senior Scientists and above actively working in the #pharmaceutical / #biotech industry. Each roundtable is limited to 8 participants. #hubXchangeNotAConference #pharma #bigdata #datasciences #lifesciences #drugdevelopment #pharmacology #genomics #advancedtherapies #therapeutics #therapies #antibodytherapeutics #antibodyoptimisation #antibodydiscovery #emergingtechnologies #targetedtherapies

Read the first article in a series on the potential use of CD8 ImmunoPET in the Knowledge Hub on our website. Discover how the mechanism of action (MoA) of immuno-oncology drug candidates is shedding light on its applications in clinical trials. Click here to read: https://lnkd.in/g7EtTptB #ImaginAb #immunooncology #CD8 ImmunoPET #biotech #pharma

Session 1 of our #Biopharma webinar series is now available on demand! ⏭ Next up: New approaches to #Peptide analysis on April 16th. Join us or register for access 📌 #protein #bioanalysis #LCMS #HPLC #peptide #MAM #Oligonucleotides #Webinar

Not long to go now until the Festival of Biologics Basel!  Discover how our innovative solutions can accelerate your biologics research and development. From advanced analytical instruments to comprehensive workflow solutions, we have everything you need to drive your projects forward. Don’t miss out on the chance to connect with our experts and explore how Agilent can support your scientific research. Attend our talk: https://lnkd.in/gdZDuaR7 #AgilentEMEA #Genomics #Festofbiologics

📍A new #webinar will be organised by FIP Industrial Pharmacy Section on 24th September 2024, 3pm CET, with the topic: "Artificial Intelligence for the Design of New RNA Nanocarriers''. Our speaker will be Olivia Merkel, Professor of Drug Delivery Ludwig Maximillian University (LMU), Munich, Germany. Read more details and secure your attendance by *registering* via the link below 👇 https://lnkd.in/eCCdvZhT After participating in this webinar, attendees will be able to : 1) Understand what the current barriers for RNA therapeutics are 2) Learn how artificial intelligence can speed up the search for better RNA nanocarriers International Pharmaceutical Federation (FIP) #fipdigitalevents #fip #pharmacy

Join Novotech for an informative webinar on May 8, 2024, at 3-4 pm CST, where we will explore the Bioassay Platform for Small Nucleic Acid Drug Analysis: PK, PD, and Immunogenicity. Our experts, Ian Yeh (葉斯寧) and Thomas Tang (湯偉辰), will do a deep dive into the importance of bioassays in advancing clinical drug development and meeting the demands of monitoring therapeutic drugs. Register now and gain the insights needed into one of the most dynamic areas in drug development. #Bioassay #ClinicalTrials #Novotech